Literature DB >> 19212130

Sex hormones and modulation of immunity against leishmaniasis.

Heidi Snider1, Claudio Lezama-Davila, James Alexander, Abhay R Satoskar.   

Abstract

Sex-associated hormones such as estradiol, testosterone and progesterone have all been shown to modulate immune responses, which can result in differential disease outcomes between males and females, as well as between pregnant and nonpregnant females. Most parasitic diseases, including leishmaniasis, usually result in more severe disease in males compared with females. This review highlights our current knowledge concerning the role of sex hormones in modulating leishmaniasis in both clinical settings and experimental disease models. Copyright (c) 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19212130      PMCID: PMC2760305          DOI: 10.1159/000180265

Source DB:  PubMed          Journal:  Neuroimmunomodulation        ISSN: 1021-7401            Impact factor:   2.492


  82 in total

Review 1.  The interaction of Leishmania species with macrophages.

Authors:  J Alexander; D G Russell
Journal:  Adv Parasitol       Date:  1992       Impact factor: 3.870

2.  Modulation of Leishmania donovani infection and cell viability by testosterone in bone marrow-derived macrophages: signaling via surface binding sites.

Authors:  Limin Liu; W Peter M Benten; Lianyun Wang; Xiangfang Hao; Qiaoli Li; Huaping Zhang; Dongxing Guo; Yajing Wang; Frank Wunderlich; Zhongdong Qiao
Journal:  Steroids       Date:  2005-08       Impact factor: 2.668

3.  Tumor necrosis factor-alpha in combination with interferon-gamma, but not with interleukin 4 activates murine macrophages for elimination of Leishmania major amastigotes.

Authors:  C Bogdan; H Moll; W Solbach; M Röllinghoff
Journal:  Eur J Immunol       Date:  1990-05       Impact factor: 5.532

4.  Pregnancy impairs resistance of C57BL/6 mice to Leishmania major infection.

Authors:  O G Arinola; J S Louis; F Tacchini-Cottier; A Aseffa; L S Salimonu
Journal:  Afr J Med Med Sci       Date:  2005-03

5.  Sex-influenced population kinetics of Leishmania donovani in hamsters.

Authors:  R Pal; J C Katiyar
Journal:  Indian J Exp Biol       Date:  1990-09       Impact factor: 0.818

6.  Sex differences and cross-immunity in DBA/2 mice infected with L. mexicana and L. major.

Authors:  J Alexander
Journal:  Parasitology       Date:  1988-04       Impact factor: 3.234

7.  Langerhans cells transport Leishmania major from the infected skin to the draining lymph node for presentation to antigen-specific T cells.

Authors:  H Moll; H Fuchs; C Blank; M Röllinghoff
Journal:  Eur J Immunol       Date:  1993-07       Impact factor: 5.532

8.  Estrogen regulates the IFN-gamma promoter.

Authors:  H S Fox; B L Bond; T G Parslow
Journal:  J Immunol       Date:  1991-06-15       Impact factor: 5.422

9.  IL-4 induces a Th2 response in Leishmania major-infected mice.

Authors:  R Chatelain; K Varkila; R L Coffman
Journal:  J Immunol       Date:  1992-02-15       Impact factor: 5.422

10.  Enhancing effect of 17 beta-estradiol on human NK cell activity.

Authors:  K Sorachi; S Kumagai; M Sugita; J Yodoi; H Imura
Journal:  Immunol Lett       Date:  1993-04       Impact factor: 3.685

View more
  26 in total

1.  Female spontaneously hypertensive rats have greater renal anti-inflammatory T lymphocyte infiltration than males.

Authors:  Ashlee J Tipton; Babak Baban; Jennifer C Sullivan
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-07-03       Impact factor: 3.619

2.  Blastocystis spp., Cryptosporidium spp., and Entamoeba histolytica exhibit similar symptomatic and epidemiological patterns in healthcare-seeking patients in Karachi.

Authors:  Syeda Sadaf Haider; Rakhshanda Baqai; Fouad M Qureshi; Kenneth Boorom
Journal:  Parasitol Res       Date:  2012-07-05       Impact factor: 2.289

3.  In situ immunopathological changes in cutaneous leishmaniasis due to Leishmania donovani.

Authors:  N H Manamperi; S Oghumu; N Pathirana; M V C de Silva; W Abeyewickreme; A R Satoskar; N D Karunaweera
Journal:  Parasite Immunol       Date:  2017-03       Impact factor: 2.280

4.  Level of circulating steroid hormones in malaria and cutaneous leishmaniasis: a case control study.

Authors:  Farideh Esfandiari; Bahador Sarkari; Habibollah Turki; Nasir Arefkhah; Najme Shakouri
Journal:  J Parasit Dis       Date:  2018-11-20

5.  Immunological basis for the gender differences in murine Paracoccidioides brasiliensis infection.

Authors:  Camila Figueiredo Pinzan; Luciana Pereira Ruas; Anália Sulamita Casabona-Fortunato; Fernanda Caroline Carvalho; Maria-Cristina Roque-Barreira
Journal:  PLoS One       Date:  2010-05-21       Impact factor: 3.240

6.  Increased risk of fatal infections in women starting peritoneal dialysis.

Authors:  Silvia Ros; Cesar Remón; Abdul Rashid Qureshi; Pedro Quiros; Bengt Lindholm; Juan Jesús Carrero
Journal:  Perit Dial Int       Date:  2013-10-01       Impact factor: 1.756

7.  Parasites or cohabitants: cruel omnipresent usurpers or creative "éminences grises"?

Authors:  Marcos A Vannier-Santos; Henrique L Lenzi
Journal:  J Parasitol Res       Date:  2011-07-18

8.  Epidemiological and Experimental Evidence for Sex-Dependent Differences in the Outcome of Leishmania infantum Infection.

Authors:  Nilda E Rodríguez; Iraci D Lima; Upasna Gaur Dixit; Elizabeth A Turcotte; Ryan D Lockard; Hemali Batra-Sharma; Eliana L Nascimento; Selma M B Jeronimo; Mary E Wilson
Journal:  Am J Trop Med Hyg       Date:  2018-01       Impact factor: 2.345

Review 9.  The effect of statins on testosterone in men and women, a systematic review and meta-analysis of randomized controlled trials.

Authors:  C Mary Schooling; Shiu Lun Au Yeung; Guy Freeman; Benjamin J Cowling
Journal:  BMC Med       Date:  2013-02-28       Impact factor: 8.775

10.  Risk factors for visceral leishmaniasis and asymptomatic Leishmania donovani infection in India and Nepal.

Authors:  Albert Picado; Bart Ostyn; Shri Prakash Singh; Surendra Uranw; Epco Hasker; Suman Rijal; Shyam Sundar; Marleen Boelaert; François Chappuis
Journal:  PLoS One       Date:  2014-01-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.